Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer (Q45329344)
Jump to navigation
Jump to search
scientific article published on 24 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer |
scientific article published on 24 July 2013 |
Statements
1 reference
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer (English)
1 reference
Hoon-Kyo Kim
1 reference
Dae Ho Lee
1 reference
Jung Shin Lee
1 reference
Sang-We Kim
1 reference
José Rodrigues-Pereira
1 reference
Baohui Han
1 reference
Xiang-Qun Song
1 reference
Jie Wang
1 reference
Tarini Prasad Sahoo
1 reference
Raghunadharao Digumarti
1 reference
Xin Wang
1 reference
Sedat Altug
1 reference
Mauro Orlando
1 reference
24 July 2013
1 reference
1 reference
49
1 reference
15
1 reference
3111-3121
1 reference
Identifiers
1 reference
1 reference